Compliance posture
TEHNOFARM operates across regulated domains: pharmaceutical raw-material cultivation, intellectual property, and applied medical software. Each domain has its own regulatory frame. The company's working position is that compliance claims must be backed by evidence; no certification or status is asserted without documentation.
Operating principle
No claim without evidence.
The company does not describe itself as compliant, certified, or certification-ready unless the supporting evidence exists and the specific wording has been reviewed. Status language reflects actual state — in development, trademark filed, manufacturing specification locked, cultivation phase, target Q3 2026 — and is updated only when the underlying state changes.
Phytosanitary registration
Cultivation operations through NORD NUC S.R.L. are registered with the National Agency for Food Safety (ANSA) of the Republic of Moldova. The registration covers Producer, Importer, and Phytosanitary User activities under ANSA Certificate Nr. 2510401546, registered 20 September 2021. Cultivated areas across the origin programmes are documented in the ANSA registry and reflected on the relevant programme pages.
Intellectual-property registry
Trademark registrations are maintained at AGEPI, the Moldovan State Agency for Intellectual Property. Five marks are registered under TEHNOFARM S.R.L. ownership; see the trademark registry →. The patent family operating across the TF Group is maintained through TF Intelligence Platform S.R.L., with filings at AGEPI structured for international extension under the Paris Convention following Moldova's EPO accession on 1 June 2026. See the patent family overview →
Pharmaceutical raw-material supply
Origin programmes operate under documented analytical protocols. Full phytochemical and microbiological dossiers, pesticide-residue panels, and origin-validation records are provided to qualifying B2B partners under NDA. Specification documents follow ICH Q1A R2 stability principles for material destined for pharmaceutical extraction.
Applied medical software (T.E.H.N.O.F.A.R.M. OS)
TF Intelligence Platform's applied medical software — T.E.H.N.O.F.A.R.M. OS, in development — is being designed in advance to meet the standards of the European Union AI Act framework for high-risk and medical AI systems. Each release will carry documentation of governance rules, evidence trails, model lineage, and physician-review chains appropriate to the deployment context. The governance frame — a written constitutional document and an operator oath — is publicly described at /programs/tehnofarm-os/; the full text is released to qualifying partners under NDA.
Data protection
The TF Group processes personal data under GDPR-equivalent obligations where applicable. The privacy notice for this website is at /privacy-policy/. Data-processing agreements with partners, including the data-protection impact assessment relevant to T.E.H.N.O.F.A.R.M. OS deployments, are produced as part of the partner engagement framework.
Engagement on regulatory questions
Regulatory reviewers, due-diligence teams, and compliance officers may request institutional documentation through contact@tehnofarm.md. Subject line: Compliance inquiry. Specific documentation released depends on the nature of the inquiry and the standard institutional confidentiality framework.